COVID-19 oral treatment (Paxlovid)

Paxlovid is the first specific oral treatment for COVID-19. It comes in tablet form.

Although Paxlovid does not prevent COVID-19 or replace vaccination against COVID-19, it is intended to reduce the severity of COVID-19 symptoms in people at risk of developing serious complications from this infection. It is estimated to reduce the risk of hospitalization or death from COVID-19.

Eligibility criteria and details

To find out if you are eligible to receive Paxlovid, please consult the following links:


Consumer information on Paxlovid is available on the Government of Canada’s website.

By continuing, you consent to sharing personal information with Pharmacie Raji Al-Kurdi Inc, Affliated with Mednow